These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38201570)
1. PI3Kδ Inhibition Potentiates Glucocorticoids in B-lymphoblastic Leukemia by Decreasing Receptor Phosphorylation and Enhancing Gene Regulation. Zimmerman JAO; Fang M; Pufall MA Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201570 [TBL] [Abstract][Full Text] [Related]
2. PI3Kδ inhibition potentiates glucocorticoids in B-lymphoblastic leukemia by decreasing receptor phosphorylation and enhancing gene regulation. Zimmerman JAO; Fang M; Pufall MA bioRxiv; 2023 Aug; ():. PubMed ID: 36798391 [TBL] [Abstract][Full Text] [Related]
3. Suppression of B-cell development genes is key to glucocorticoid efficacy in treatment of acute lymphoblastic leukemia. Kruth KA; Fang M; Shelton DN; Abu-Halawa O; Mahling R; Yang H; Weissman JS; Loh ML; Müschen M; Tasian SK; Bassik MC; Kampmann M; Pufall MA Blood; 2017 Jun; 129(22):3000-3008. PubMed ID: 28424165 [TBL] [Abstract][Full Text] [Related]
6. Idelalisib: A Novel PI3Kδ Inhibitor for Chronic Lymphocytic Leukemia. Shah A; Mangaonkar A Ann Pharmacother; 2015 Oct; 49(10):1162-70. PubMed ID: 26185276 [TBL] [Abstract][Full Text] [Related]
7. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells]. He L; Li D; Hou KZ; Liu YP Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564 [TBL] [Abstract][Full Text] [Related]
8. AKT1 has dual actions on the glucocorticoid receptor by cooperating with 14-3-3. Habib T; Sadoun A; Nader N; Suzuki S; Liu W; Jithesh PV; Kino T Mol Cell Endocrinol; 2017 Jan; 439():431-443. PubMed ID: 27717743 [TBL] [Abstract][Full Text] [Related]
9. The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALL. Adam E; Kim HN; Gang EJ; Schnair C; Lee S; Lee S; Khazal S; Kosoyan O; Konopleva M; Parekh C; Bhojwani D; Wayne AS; Abdel-Azim H; Heisterkamp N; Kim YM Cancers (Basel); 2017 Sep; 9(9):. PubMed ID: 28891959 [TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis. Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075 [TBL] [Abstract][Full Text] [Related]
11. P38 MAPK and glucocorticoid receptor crosstalk in bronchial epithelial cells. Lea S; Li J; Plumb J; Gaffey K; Mason S; Gaskell R; Harbron C; Singh D J Mol Med (Berl); 2020 Mar; 98(3):361-374. PubMed ID: 31974640 [TBL] [Abstract][Full Text] [Related]
12. The role of glucocorticoid receptor phosphorylation in Mcl-1 and NOXA gene expression. Lynch JT; Rajendran R; Xenaki G; Berrou I; Demonacos C; Krstic-Demonacos M Mol Cancer; 2010 Feb; 9():38. PubMed ID: 20156337 [TBL] [Abstract][Full Text] [Related]
13. PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by Li J; Hlavka-Zhang J; Shrimp JH; Piper C; Dupéré-Richér D; Roth JS; Jing D; Casellas Román HL; Troche C; Swaroop A; Kulis M; Oyer JA; Will CM; Shen M; Riva A; Bennett RL; Ferrando AA; Hall MD; Lock RB; Licht JD Cancer Discov; 2022 Jan; 12(1):186-203. PubMed ID: 34417224 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous targeting of PI3Kδ and a PI3Kδ-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia. Wang X; Zhang X; Li BS; Zhai X; Yang Z; Ding LX; Wang H; Liang C; Zhu W; Ding J; Meng LH Oncotarget; 2014 Nov; 5(21):10732-44. PubMed ID: 25313141 [TBL] [Abstract][Full Text] [Related]
15. Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation. He LX; Yang L; Liu T; Li YN; Huang TX; Zhang LL; Luo J; Liu CT Respir Res; 2023 Mar; 24(1):90. PubMed ID: 36949482 [TBL] [Abstract][Full Text] [Related]